Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000549331 | SCV000637010 | likely benign | Brugada syndrome | 2024-08-31 | criteria provided, single submitter | clinical testing | |
Gene |
RCV001584268 | SCV001811511 | likely benign | not provided | 2019-11-20 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002431590 | SCV002743513 | likely benign | Cardiovascular phenotype | 2019-07-11 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Fulgent Genetics, |
RCV002497116 | SCV002807367 | likely benign | Episodic pain syndrome, familial, 2 | 2021-07-23 | criteria provided, single submitter | clinical testing | |
Ce |
RCV001584268 | SCV005434340 | likely benign | not provided | 2024-11-01 | criteria provided, single submitter | clinical testing | SCN10A: BP4, BP7 |